BCC and HNSCC tumorigenesis have been shown to be associated with an aberrant canonical Hh/GLI signaling pathway, mostly due to loss-of-function mutations in PTCH1, or gain-of-function mutations in SMO [6,21,31]. The gene discussed is SMO; the disease is skin basal cell carcinoma.